A Study of Daratumumab, Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Newly-Diagnosed Multiple Myeloma
Clinical trial NCT04268498 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04268498
- Sponsor
- University of Miami
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-11
- Primary completion
- 2027-02-01
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.